FORM 10-QSB
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                 ---------------

              [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D)
                     OF THE SECURITIES EXCHANGE ACT OF 1934

                  FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2004

                                       OR

              [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D)
                     OF THE SECURITIES EXCHANGE ACT OF 1934

                 FOR THE TRANSITION PERIOD FROM ______ TO _____

                         COMMISSION FILE NUMBER 1-10927

                                  SIMTROL, INC.
        (EXACT NAME OF SMALL BUSINESS ISSUER AS SPECIFIED IN ITS CHARTER)


    DELAWARE                                            84-1104448
   (STATE OF                                        (I.R.S. EMPLOYER
 INCORPORATION)                                     IDENTIFICATION NO.)

                        2200 NORCROSS PARKWAY, SUITE 255
                             NORCROSS, GEORGIA 30071
          (ADDRESS OF PRINCIPAL EXECUTIVE OFFICES, INCLUDING ZIP CODE)

                                 (770) 242-7566
                (ISSUER'S TELEPHONE NUMBER, INCLUDING AREA CODE)

Indicate by check mark whether the issuer (1) has filed all reports required to
be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
the preceding 12 months, and (2) has been subject to such filing requirements
for the past 90 days.

    YES |X|                                                   NO |_|

Indicate the number of shares outstanding of each of the issuer's classes of
common stock, as of the latest practicable date.

                                                             OUTSTANDING AT
    CLASS OF SECURITIES                                       MAY 14, 2004
    -------------------

COMMON STOCK, $.001 PAR VALUE                                2,336,723


Transitional Small Business Disclosure Format:  YES |_|        NO |X|
                                                                   -





                         SIMTROL, INC. AND SUBSIDIARIES

                                   Form 10-QSB
                          Quarter Ended March 31, 2004

                                      Index


                                                                            Page


PART I.    FINANCIAL INFORMATION

          Item 1. Financial Statements (Unaudited):

                  Condensed Consolidated Balance Sheet as of
                  March 31, 2004 ........................................      3

                  Condensed Consolidated Statements of Operations for the
                  Three Months Ended March 31, 2004 and 2003 ............      4

                  Condensed Consolidated Statements of Cash Flows for the
                  Three Months Ended March 31, 2004 and 2003 ............      5

                  Notes to Condensed Consolidated Financial Statements ..      6

          Item 2. Management's Discussion and Analysis of
                  Financial Conditionand Results of Operations .........      10

          Item 3. Controls and Procedures ..............................      13

PART II  OTHER INFORMATION

          Item 1. Legal Proceedings ..........................................14

          Item 2. Changes in Securities and Purchases of Equity Securities .. 14

          Item 6. Exhibits and Reports on Form 8-K .......................... 14


                                        2



                                  SIMTROL, INC.
                         PART I - FINANCIAL INFORMATION

ITEM 1.  FINANCIAL STATEMENTS

                         SIMTROL, INC. AND SUBSIDIARIES
                      CONDENSED CONSOLIDATED BALANCE SHEET
                                 MARCH 31, 2004

                                   (UNAUDITED)

                             ASSETS

Current assets:
     Cash and cash equivalents                                     $     94,233
     Accounts receivable, net                                            31,916
     Capitalized financing costs                                        148,978
                                                                   ------------
           Total current assets                                         275,127

Property and equipment, net                                              69,115

Other long-term assets                                                   11,187
                                                                   ------------
                 Total assets                                      $    355,429
                                                                   ============

     LIABILITIES AND STOCKHOLDERS' DEFICIENCY

Current Liabilities:
     Current portion of long-term debt and short-term borrowings   $    185,065
     Convertible debt, net of unamortized discounts of $145,629         849,371
     Accounts payable                                                   602,587
     Accrued expenses                                                   591,967
     Deferred revenues                                                    6,037
                                                                   ------------
           Total Current Liabilities                                  2,235,027

Long-term debt, less current portion                                     41,920

Commitments and contingencies

Stockholders' deficiency:
     Common stock, authorized 40,000,000 shares of
          $.001 par value; 2,336,723 issued and outstanding               2,337
     Additional paid-in capital                                      60,034,533
     Accumulated deficit                                            (61,958,388)
                                                                   ------------
                 Total stockholders' deficiency                      (1,921,518)
                                                                   ------------
                Total liabilities and stockholders' deficiency     $    355,429
                                                                   ============
See notes to condensed consolidated financial statements.


                                        3



                         SIMTROL, INC. AND SUBSIDIARIES
                 CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
                                   (UNAUDITED)


                                                THREE MONTHS ENDED
                                                     MARCH 31,
                                                 2004           2003
                                           -------------- --------------
Revenues:
  Software licenses                          $    25,816    $    34,492
  Service                                         25,042        115,813
                                             -----------    -----------
      Total revenues                              50,858        150,305
Cost of revenues
  Software licenses                               70,522         71,000
  Service                                           --           56,510
                                             -----------    -----------
      Total cost of revenues                      70,522        127,510
                                             -----------    -----------
      Gross (loss) profit                        (19,664)        22,795

Operating expenses:
    Selling, general, and administrative         271,547        131,390
    Research and development                     107,349        102,022
                                             -----------    -----------
Total operating expenses                         378,896        233,412

      Loss from operations                      (398,560)      (210,617)

Other income/(expenses)
  Gain on debt extinguishment                    254,302           --
  Other expense, primarily finance charges      (162,749)       (59,973)
  Debt conversion expense                           --         (431,599)
                                             -----------    -----------
Total other income (expenses)                     91,553       (491,572)

      Net loss                               $  (307,007)   $  (702,189)
                                             ===========    ===========

Net loss per common share:
    Basic and Diluted                        $     (0.13)   $     (0.35)
Weighted average shares outstanding
    Basic and diluted                          2,336,494      2,010,062
                                             ===========    ===========

See notes to condensed consolidated financial statements.


                                        4



                         SIMTROL, INC. AND SUBSIDIARIES
                 CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
                                   (UNAUDITED)



                                                                           THREE MONTHS ENDED
                                                                                MARCH 31,
                                                                           2004         2003
                                                                        ---------    ---------
CASH FLOWS FROM OPERATING ACTIVITIES:
                                                                               
             Net cash used in operating activities                       (392,565)    (163,979)

CASH FLOWS FROM INVESTING ACTIVITIES:
             Net cash provided by investing activities                       --           --

CASH FLOWS FROM FINANCING ACTIVITIES:
     Net (payments) on short-term credit facilities                        (1,200)      (4,891)
     Net proceeds from convertible debt                                   479,000       30,000
    Net proceeds from stock issuances                                       5,000      142,600
                                                                        ---------    ---------
             Net cash provided by financing activities                    482,800      167,709


Increase (decrease) in cash and cash equivalents                           90,235        3,730
Cash and cash equivalents, beginning of the period                          3,998        1,307
                                                                        ---------    ---------
Cash and cash equivalents, end of the period                            $  94,233    $   5,037
                                                                        =========    =========

Supplemental schedule of non-cash investing and financing activities:
    Issuance of stock warrants                                          $ 192,602    $  58,460
                                                                        ---------    ---------
    Beneficial conversion feature of convertible debt                   $ 127,242    $ 229,284
                                                                        ---------    ---------
    Conversion of debt and accrued interest to common stock             $    --      $ 768,061
                                                                        ---------    ---------


See notes to condensed consolidated financial statements.


                                        5



                         SIMTROL, INC. AND SUBSIDIARIES
              NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
               FOR THE THREE MONTHS ENDED MARCH 31, 2004 AND 2003
                                   (UNAUDITED)

NOTE 1 - NATURE OF OPERATIONS AND BASIS OF PRESENTATION

Simtrol, Inc., formerly known as VSI Enterprises, Inc., was incorporated in
Delaware in September 1988 and, together with its wholly-owned subsidiaries (the
"Company"), develops, markets, and supports software-based audiovisual control
systems and videoconferencing products that operate on PC platforms.

The accompanying unaudited condensed consolidated financial statements have been
prepared by the Company in conformity with accounting principles generally
accepted in the United States of America and the instructions of Form 10-QSB. It
is management's opinion that these statements include all adjustments,
consisting of only normal recurring adjustments necessary to make the financial
position, results of operations, and cash flows not misleading as of March 31,
2004 and for all periods presented.

The preparation of financial statements in conformity with accounting principles
generally accepted in the United States of America requires management to make
estimates and assumptions that affect the reported amounts of assets and
liabilities and disclosures of contingent assets and liabilities at the date of
the financial statements and the reported amounts of revenues and expenses
during the reporting period. Actual results could differ from those estimates.

Certain information and footnote disclosures normally included in the annual
financial statements prepared in accordance with accounting principles generally
accepted in the United States of America have been condensed or omitted. It is
suggested that these condensed consolidated financial statements be read in
conjunction with the consolidated financial statements and notes thereto as of
December 31, 2003 and for each of the two years ended December 31, 2003, which
are included in the Company's Annual Report on Form 10-KSB for the year ended
December 31, 2003 filed with the Securities and Exchange Commission.

On May 7, 2004, the Company effected a 1:10 reverse split of the Company's
common stock. All share totals have been adjusted to reflect the 1:10 reverse
split for all periods presented.

NOTE 2 - GOING CONCERN UNCERTAINTY

As of March 31, 2004, the Company had cash and cash equivalents of $94,233. The
Company does not have sufficient funds for the next twelve (12) months and has
relied on periodic investments in the form of common stock and convertible debt
since the fourth quarter of 2001 to sustain its operations. The Company
currently requires substantial amounts of capital to fund current operations and
for the payment of past due obligations including payroll and other operating
expenses and the continued development and deployment of its Ongoer product
line. On February 4, 2004, the Company issued $575,000 of convertible debt (see
Note 5) and continues to attempt to raise capital. However, there can be no
assurance that the Company will be successful in its attempts to develop and
deploy its Ongoer product line, to generate positive cash flows or raise
sufficient capital essential to its survival. To the extent that the Company is
unable to generate or raise the necessary operating capital, it will become
necessary to curtail operations. Additionally, even if the Company does raise
operating capital, there can be no assurance that the net proceeds will be
sufficient to enable it to develop its business to a level where it will
generate profits and positive cash flows.

These matters raise substantial doubt about the Company's ability to continue as
a going  concern.  However,  the  accompanying  financial  statements  have been
prepared on a going concern basis,  which  contemplate the realization of assets
and satisfaction of liabilities in the normal course of business.  The financial
statements do not include any adjustments  relating to the recoverability of the
recorded assets or the classification of the liabilities that might be necessary
should the Company be unable to continue as a going concern.


                                        6



NOTE 3 - SELECTED SIGNIFICANT ACCOUNTING POLICIES

Principles of Consolidation
The  condensed  consolidated  financial  statements  include the accounts of the
Company  and  its  wholly-owned   subsidiaries.   All  significant  intercompany
transactions and balances have been eliminated in consolidation.

Loss Per Share
Statement of Financial  Accounting  Standards  ("SFAS") No. 128,  "Earnings  per
Share",  requires  the  presentation  of basic and  diluted  earnings  per share
("EPS"). Basic EPS is computed by dividing loss available to common stockholders
by the  weighted-average  number of common  shares  outstanding  for the period.
Diluted EPS includes the potential dilution that could occur if options or other
contracts to issue  common stock were  exercised  or  converted.  The  following
equity  securities  are not  reflected in diluted loss per share  because  their
effects would be anti-dilutive:

              March 31, 2004        March 31, 2003
              --------------        --------------
Options              137,525               97,450
Warrants             900,923              306,871
Convertible Debt     488,569              200,040
                   ---------            ---------
Total              1,527,017              604,361
                   ---------            ---------

Accordingly, basic and diluted loss per share are identical.

Stock Based Compensation

SFAS No. 148, "Accounting for Stock-Based Compensation-Transition and
Disclosure-an amendment of FASB Statement No. 123" amends SFAS No. 123,
"Accounting for Stock-Based Compensation", to provide alternative methods of
transition for a voluntary change to the fair value based method of accounting
for stock-based employee compensation. In addition, this Statement amends the
disclosure requirements of SFAS 123 to require prominent disclosures in both
annual and interim financial statements about the method of accounting for
stock-based compensation and the effect of the method used on reported results.
The Company continues to follow the pro-forma disclosures for stock-based
compensation as permitted in SFAS 123. The following table illustrates the
effect on net loss per share if the Company had applied the fair value
recognition provisions of SFAS 123 to stock-based employee compensation:

                                                      Three Months Ended
                                                           March 31,
                                                       2004          2003
                                                  ==========================
Net loss as reported                                ($307,007)   ($702,189)

Add: stock-based employee compensation expense
determined under the intrinsic value method              --           --
Less:  stock-based employee compensation expense
determined under fair value-based methods for all
awards                                                 (7,789)     (68,122)
                                                    ---------    ---------
Pro forma net loss                                  ($314,796)   ($770,311)
                                                    ==========   =========

Net loss per share as reported-Basic and diluted    ($   0.13)   ($   0.35)
Pro forma net loss per share- Basic and diluted     ($   0.13)   ($   0.38)


                                        7



Pro forma Information

The fair value for the fiscal 2004 and 2003 options  issued was estimated at the
date of grant using a Black-Scholes  option-pricing  model to be $0 and $86,667,
respectively, with the following weighted-average assumptions.

Assumptions                          2004           2003
                                  ---------     ---------

Risk-free rate                      4.00%          4.00%
Annual rate of dividends                0              0
Volatility                            85%            86%

Average life                      7 years        7 years

The Black-Scholes option valuation model was developed for use in estimating the
fair value of traded options, which have no vesting restrictions and are fully
transferable. In addition, option valuation models require the input of highly
subjective assumptions including the expected stock price volatility. The
Company's employee stock options have characteristics significantly different
from those of traded options, and changes in the subjective input assumptions
can materially affect the fair value estimate.

The  following  summarizes  the stock option  transactions  for the three months
ended March 31, 2004 and 2003:

                                                                    Weighted
                                                                     Average
                                                                    Exercise
                                                  Options              Price
                                               ----------          ---------
Options outstanding at January 1, 2003             97,450             $17.60
Granted                                                 -                  -
Exercised                                               -                  -
Terminated                                              -                  -
                                               -----------
Options outstanding at March 31, 2003              97,450             $17.60
                                               ===========

Options outstanding at January 1, 2004            137,525             $13.20
Granted                                                 -
Exercised                                               -
Terminated                                              -
Options outstanding at March 31, 2004             137,525             $13.20
                                               ===========


New Accounting Pronouncements

In January 2003,  Financial  Accounting  Standards  Board  ("FASB")  issued FASB
Interpretation No. 46, "Consolidation of Variable Interest Entities" ("FIN 46"),
an  interpretation  of Accounting  Research Bulletin No. 51. FIN 46 expands upon
and  strengthens  existing  accounting  guidance that  addresses  when a company
should  include  in  its  financial  statements  the  assets,   liabilities  and
activities of another entity. A variable  interest entity is any legal structure
used for  business  purposes  that either does not have  equity  investors  with
voting rights or has equity investors that do not provide  sufficient  financial
resources for the entity to support its  activities.  FIN 46 requires a variable
interest  entity to be consolidated by a company if that company is subject to a
majority of the risk of loss from the variable interest  entity's  activities or
entitled to receive a majority of the  entity's  residual  returns or both.  The
consolidation  requirements  of FIN 46 apply  immediately  to variable  interest
entities created after January 31, 2003. The consolidation requirements apply to
older entities in the first fiscal year or interim period  beginning  after June
15, 2003.  However, in December 2003, FASB deferred the latest date by which all
public  entities,  which meet the definition of small business  issuer under SEC
Regulation  S-B,  must  apply FIN 46 to the first  interim  or annual  reporting
period ended after  December  15,  2004.  The effect of the adoption of this new


                                        8



accounting  pronouncement  is not expected to have a  significant  impact on the
Company's financial statements.

Revenue Recognition

The Company's revenue recognition policy is significant because revenue is a key
component of its results of operations. Revenue recognition also determines the
timing of certain expenses. The Company follows very specific and detailed
guidelines in measuring revenue; however, certain judgments affect the
application of our revenue policy. Revenue results are difficult to predict, and
any shortfall in revenue or delay in recognizing revenue could cause the
Company's operating results to vary significantly from quarter to quarter and
could result in future operating losses. Revenue consists of the sale of
software control devices, videoconferencing systems and related maintenance
contracts on these systems. The Company sold two different products during the
presented periods: its PC based software product, Ongoer, and its older
proprietary hardware and software product, Omega. Revenue on the sale of
hardware is recognized upon shipment. The Company recognizes revenue from Ongoer
software sales upon shipment as the Company sells the product to audiovisual
integrators. Revenue on maintenance contracts for Omega systems is recognized
over the term of the related contract resulting in $6,037 of deferred revenue at
March 31, 2004.

NOTE 4 - COMMITMENTS AND CONTINGENCIES

The Company is involved in various claims and legal actions arising in the
ordinary course of business. In the opinion of management, the ultimate
disposition of these matters will not have a material adverse effect on the
Company's financial position or results of operations.

NOTE 5 - CONVERTIBLE DEBT

On February 4, 2004, the Company completed the sale of convertible notes with
principal balance of $575,000 ("2004 Debt"), in a private placement to a limited
number of accredited investors, including $15,000 to one Board member. The
interest rate of the notes is 10% and the conversion price of the Notes is $2.00
per share for all principal and accrued interest. The due date of the notes is
August 4, 2004 and the notes are convertible to shares of common stock at any
time before that date.

The Company also issued warrants to the Noteholders to purchase an aggregate of
287,500 shares of common stock with an exercise price of $2.00. Each warrant
enables the holder to purchase the same number of shares as the holder would
receive upon conversion of the 2004 Debt. In conjunction with the issuance of
the 2004 Debt, the Company issued 169,000 warrants to Westminster Securities as
a placement fee for the financing. In addition, Noteholders received additional
warrants to purchase an aggregate of 575,000 shares of stock. Each warrant
entitles the holder to purchase two shares of common stock for each share the
holder would receive upon conversion of the Convertible Note, but the warrants
may only be exercised in the event a holder actually elects to convert the
Convertible Note into the Registrant's common stock. The exercise price of the
warrants is $2.00 per share of common stock.

Offering costs totaled approximately $96,000 and the proceeds of the offering
were used to fund current operational and overhead expenses.

In connection with the issuance of the 2004 Debt, $91,202 and $179,789 of the
proceeds was allocated to the fair value of the warrants granted to purchase
287,500 and 575,000 shares of stock, respectively, and a beneficial conversion
feature of $127,242 was recorded to reflect the discount on the 2004 Debt based
on the relative fair values of the warrants and conversion feature of the 2004
Debt. These debt discounts are amortized to financing costs over the term of the
2004 Debt, except for the $179,789 attributed to the 575,000 warrants that can
be exercised in the event of a conversion of the 2004 Debt. If any or all of the
2004 Debt is converted, the Company will record a portion or all of the $179,789
as debt conversion expense. For the three months ended March 31, 2004, $72,815
was expensed as financing costs relating to the amortization of the beneficial
conversion feature and warrant value. Additionally, $101,400 was capitalized as
a financing fee for the warrants granted to Westminster Securities and this
amount is amortized over the life of the 2004 Debt. Approximately $33,800 of
this amount was amortized as a finance expense in the three months ended March
31, 2004.


                                        9



NOTE 6 - STOCKHOLDERS' DEFICIENCY

During the three months ended March 31, 2004, the Company issued 2,604 shares of
its common stock for gross proceeds of $5,000 ($1.92 per share). During the
three months ended March 31, 2003, the Company issued 59,417 shares of its
common stock for gross proceeds of $142,600 ($2.40 per share), in a private
placement to a limited number of accredited investors, including three members
of the Company's Board. Offering costs were de minimis.

NOTE 7- MAJOR CUSTOMERS

Revenue from Telaid Industries, Polycom, and Lockheed Martin of $32,661,
$11,266, and $6,931, respectively, comprised approximately 100% of consolidated
revenues for the three months ended March 31, 2004. At March 31, 2004, related
accounts receivable from these companies comprised 100% of consolidated
receivables.

Revenue from Lockheed Martin, MCI, Polycom, and Duracell of $38,960, $32,826,
$18,846, and $17,220, respectively, comprised approximately 71% of consolidated
revenues for the three months ended March 31, 2003.

NOTE 8 - GAIN ON DEBT EXTINGUISHMENT

A gain of $254, 302 was recorded during the three months ended March 31, 2004 as
a result of the Company entering into various settlement agreements with
vendors. The gains were recorded at the time of the final payments under the
various agreements.

ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS
OF OPERATIONS

The following  discussion  highlights the material factors affecting our results
of operations and the significant  changes in the balance sheet items. The notes
to our condensed  consolidated  financial statements included in this report and
the notes to our consolidated  financial  statements included in our Form 10-KSB
for the year ended  December  31, 2003 should be read in  conjunction  with this
discussion and our consolidated financial statements.

                          CRITICAL ACCOUNTING POLICIES

We prepare our condensed  consolidated  financial  statements in conformity with
accounting  principles  generally  accepted in the United States of America.  As
such, we are required to make certain estimates,  judgments and assumptions that
we believe are reasonable based upon the information available.  These estimates
and  assumptions  affect the reported  amounts of assets and  liabilities at the
date of the  financial  statements  and the  reported  amounts of  revenues  and
expenses during the periods presented. The significant accounting policies which
we believe are the most critical to aid in fully  understanding  and  evaluating
our reported financial results include the following:

o    Revenue recognition.  Our revenue recognition policy is significant because
     our revenue is a key component of our results of  operations.  In addition,
     our  revenue  recognition  determines  the timing of certain  expenses.  We
     follow very specific and detailed guidelines in measuring revenue; however,
     certain  judgments  affect the application of our revenue  policy.  Revenue
     results are difficult to predict,  and any shortfall in revenue or delay in
     recognizing revenue could cause our operating results to vary significantly
     from  quarter  to  quarter  and could  result in future  operating  losses.
     Revenue consists of the sale of software control devices, videoconferencing
     systems and related  maintenance  contracts on these  systems.  The Company
     sold two  different  products  during the presented  periods:  its PC based
     software  product  Ongoer and its older  proprietary  hardware and software
     product,  Omega.  Revenue  on the  sale  of  hardware  is  recognized  upon
     shipment.  The Company  recognizes  revenue from Ongoer software sales upon
     shipment  as the  Company  sells the  product to  audiovisual  integrators.
     Revenue on Omega  maintenance  contracts is recognized over the term of the
     related contract.

o    Capitalized   software  research  and  development  costs.  Our  policy  on
     capitalized  software  costs  determines  the timing of our  recognition of
     certain development costs. In addition,  this policy determines whether the
     cost  is  classified  as  development  expense  or  capitalized.   Software
     development costs incurred after technological


                                       10



     feasibility has been established are capitalized and amortized,  commencing
     with product release, using the greater of the income forecast method or on
     a  straight-line  basis over the useful life of the product.  Management is
     required to use professional  judgment in determining  whether  development
     costs meet the criteria for immediate expense or capitalization.

o     Impairments of Assets/Investments. We record impairment losses on assets
      and investments when events and circumstances indicate that the assets
      might be impaired and the undiscounted cash flows estimated to be
      generated by those assets are less than the carrying amount of those
      items. Our cash flow estimates are based on historical results adjusted to
      reflect our best estimate of future market and operating conditions. The
      net carrying value of assets not recoverable is reduced to fair value. Our
      estimates of fair value represent our best estimate based on industry
      trends and reference to market rates and transactions.

FINANCIAL CONDITION

During the quarter ended March 31, 2004, total assets increased approximately
55% to $355,429 from $229,299 at December 31, 2003. This was primarily the
result of an increase in net capitalized financing costs during the quarter of
$148,978, and an increase in cash of $90,235 resulting from the convertible debt
issued during the quarter, partly offset by decreased software development
costs, net of $69,406 due to amortization of previously capitalized software
costs during the quarter.

Current liabilities  increased by $126,164, or 6%, due primarily to the issuance
of  $575,000 of  convertible  debt and during the three  months  ended March 31,
2004,  offset  partially  by a decrease  in accounts  payable of  $322,263  that
resulted principally from gains from debt extinguishments of $254,302 during the
quarter.

RESULTS OF OPERATIONS

REVENUES

Revenues were $50,858 and $150,305 for the three months ended March 31, 2004 and
2003,  respectively.  The 66% decrease for the three months ended March 31, 2004
was  primarily  due to a $90,771  reduction  in  revenues  from our older  Omega
product  line,  as  well  as  a  decrease  in  Ongoer  revenues  of  $8,676.  We
discontinued  selling our older Omega  platform in 2001 in order to  concentrate
resources on development and sale of our new Ongoer(TM)  product line. The lower
Omega revenues were due mainly to the discontinuance of maintenance contracts by
many of our customers. Our lower Ongoer sales were due mainly to the decrease in
orders from our largest Ongoer customer,  whose orders fell due to the declining
business condition of their customer for the product.

COST OF REVENUES AND GROSS PROFIT

Cost of revenues decreased $56,988, or 45%, for the three months ended March 31,
2004  compared to the three months ended March 31, 2003 due primarily to the 66%
decrease in revenues noted above.

Gross (loss) margins were approximately (39%) and 15% for the three months ended
March 31, 2004 and 2003,  respectively.  The decrease  resulted  primarily  from
lower overall revenues and the amortization of capitalized software costs, equal
to $69,406 in both periods,  representing a larger percentage of revenues in the
current year.  Amortization  of capitalized  research and  development  software
costs ended in March 31, 2004.

SELLING, GENERAL, AND ADMINISTRATIVE EXPENSES

Selling,  general,  and administrative  expenses were $271,547 and $131,390 for
the three  months ended March 31, 2004 and 2003,  respectively.  The increase in
the  three-month  period ended March 31, 2004 compared to the similar  period in
2003 resulted  primarily from accounting and auditing  expenses of approximately
$65,000 incurred during 2004, approximately $28,000 of non-refundable investment
banking  fees.  The company  filed all  required SEC filings for 2003 during the
quarter  ended March 31, 2004 and engaged  Westminster  Securities  to assist in
raising capital during the current year.


                                       11



RESEARCH AND DEVELOPMENT EXPENSES

We charge research and development costs to expense as incurred until
technological feasibility of a software product has been established. Software
development costs incurred after technological feasibility has been established
are capitalized and amortized over the useful life of the product. Research and
development costs expensed were $107,349 and $102,022 for the three months ended
March 31, 2004 and 2003, respectively. During the three months ended March 31,
2004 and 2003, we did not capitalize any software development costs related to
new products under development.

GAIN ON DEBT EXTINGUISHMENTS

A gain of $254, 302 was recorded during the three months ended March 31, 2004 to
reflect the payoffs of various liabilities for less than their previously
recorded balances. No similar debt extinguishments took place during the three
months ended March 31, 2003.

OTHER EXPENSE, PRIMARILY FINANCE CHARGES

Other expense,  primarily  finance charges of $162,749 and $59,973 for the three
months  ended March 31, 2004 and 2003  consisted  primarily  of finance  charges
associated  with our issuance of convertible  debt since the fourth quarter 2001
to fund our  operations.  See  note 5 to the  condensed  consolidated  financial
statements.  The  increase  in  interest  expense  from  the  prior  year is due
primarily to the issuance of an additional  $575,000 of convertible  debt during
the three months ended March 31, 2004.

DEBT CONVERSION EXPENSE

A debt conversion expense of $431,599 was recorded in the three months ended
March 31, 2003 to reflect the fair value of the additional shares issued to
convertible debt holders who extended their notes originally due on December 31,
2002 in exchange for a reduction of the conversion price of the debt.

NET LOSS

Net loss for the three months  ended March 31, 2004 was  $307,007  compared to a
net loss of $702,189 for the three months ended March 31, 2003.  The loss in the
three  months  ended March 31,  2003 was due  primarily  to the debt  conversion
expense of $431,599 recorded in conjunction with the conversion of a majority of
the Company's convertible debt in January 2003.

LIQUIDITY AND SOURCES OF CAPITAL

GENERAL

As of March 31, 2004,  we had cash and cash  equivalents  of $94,233.  We do not
have  sufficient  funds to meet our cash flow  requirements  for the next twelve
(12) months. We have relied on periodic  investments in the form of common stock
and convertible  debt by certain of our existing  stockholders  since the fourth
quarter of 2001 to sustain our  operations.  We  currently  require  substantial
amounts of capital to fund  current  operations  and for the payment of past due
obligations  including  payroll and other  operating  expenses and the continued
development  and deployment of our Ongoer product line. Due to recurring  losses
from  operations,  an  accumulated  deficit,  negative  working  capital and our
inability  to date  to  obtain  sufficient  financing  to  support  current  and
anticipated  levels of operations,  our independent  public  accountant's  audit
opinion  states  that these  matters  have  raised  substantial  doubt about our
ability to continue as a going concern at December 31, 2003.

We used  $392,565 in cash from  operating  activities  in the three months ended
March 31, 2004  primarily due to our loss of $307,007,  which included a gain on
debt  extinguishments  of $254,302 and the costs  associated  with filing of our
overdue  financial  filings  with the SEC,  discontinuing  the  previous  year's
deferral of a portion of employees' salaries, and reducing accounts payable with
proceeds of the convertible  debt issued during the three months ended


                                       12



March 31, 2004. The majority of the loss during the three months ended March 31,
2003 was due to debt conversion expense of $431,599. There was no cash used in
investing activities for the three months ended March 31, 2004 or the three
months ended March 31, 2003. Cash provided by financing activities in the three
months ended March 31, 2004 consisted primarily of $479,000 of net proceeds from
convertible debt issued in February 2004. Cash provided by financing activities
in the three months ended March 31, 2003 of $167,709 consisted primarily of
$142,600 of proceeds from the issuance of common stock and $30,000 of proceeds
from the issuance of convertible debt.

We will  require  additional  funding  during the  remainder  of fiscal 2004 and
thereafter to fund our  development  and operating  activities.  This additional
funding  could  be in the  form  of the  sale  of  assets,  debt,  equity,  or a
combination of these financing methods.  However, there can be no assurance that
we  will be able  to  obtain  such  financing  if and  when  needed,  or that if
obtained,  such  financing  will  be  sufficient  or  on  terms  and  conditions
acceptable  to us. If we are  unable  to obtain  this  additional  funding,  our
business,  financial  condition  and results of  operations  would be  adversely
affected.  The accompanying financial statements contemplate our continuation as
a going concern.  However, we have sustained  substantial losses from operations
in recent years, and such losses have continued  through March 31, 2004. We have
also used,  rather than  provided,  cash in our  operations for the three months
ended March 31, 2004.

In view of the matters described in the preceding paragraph, recoverability of a
major portion of the recorded  asset amounts shown in the  accompanying  balance
sheet is dependent  upon our  continued  operations,  which in turn is dependent
upon our ability to meet our financing  requirements  on a continuing  basis and
attract  additional  financing.  The  financial  statements  do not  include any
adjustments  relating to the recoverability and classification of recorded asset
amounts or amounts and  classification  of  liabilities  that might be necessary
should we be unable to continue in existence.

In  response  to the  matters  described  in the  preceding  paragraphs,  we are
currently  in the process of  attempting  to secure  additional  equity and debt
financing.

We expect to spend less than $35,000 for capital  expenditures  in the remainder
of fiscal 2004.

FORWARD-LOOKING STATEMENTS

Certain statements contained herein are "forward-looking  statements" within the
meaning  of the  Private  Securities  Litigation  Reform  Act of  1995,  such as
statements relating to financial results and plans for future sales and business
development   activities,   and  are  thus  prospective.   Such  forward-looking
statements are subject to risks,  uncertainties  and other factors,  which could
cause  actual  results to differ  materially  from future  results  expressed or
implied by such  forward-looking  statements.  Potential risks and uncertainties
include, but are not limited to, economic conditions,  competition,  our ability
to complete  the  development  and market our new Ongoer  product line and other
uncertainties  detailed  from  time  to  time  in our  Securities  and  Exchange
Commission filings, including our Annual Report on Form 10-KSB and our quarterly
reports on Form 10-QSB.

ITEM 3. CONTROLS AND PROCEDURES

We maintain  disclosure controls and procedures that are designed to ensure that
information  required to be disclosed in our Securities  Exchange Act reports is
recorded, processed,  summarized, and reported within the time periods specified
in the SEC's  rules and forms,  and that such  information  is  accumulated  and
communicated to the Company's management,  including its Chief Executive Officer
and Chief Financial Officer, as appropriate, to allow timely decisions regarding
required  disclosure.  In designing and evaluating  the disclosure  controls and
procedures,  management  recognized that any controls and procedures,  no matter
how well  designed  and  operated,  can provide  only  reasonable  assurance  of
achieving  the  desired  control  objectives,  as ours are  designed  to do, and
management  necessarily  was  required to apply its judgment in  evaluating  the
cost-benefit relationship of possible controls and procedures.

An evaluation was performed under the supervision and with the  participation of
our Company's  management,  including the Chief Executive  Officer and the Chief
Financial  Officer,  of the  effectiveness  of the design and  operation  of our
disclosure  controls  and  procedures  as of March  31,  2004.  Based  upon that
evaluation,  the  Chief  Executive  Officer  and  the  Chief  Financial  Officer


                                       13



concluded that our disclosure controls and procedures were effective. Except as
discussed in the following paragraph, subsequent to the date of this evaluation,
there have been no significant changes in the Company's internal controls or in
other factors that could significantly affect these controls.

In connection with its audit of our consolidated financial statements as of and
for the year ended December 31, 2003, Marcum & Kliegman LLP advised our
management and Audit Committee that it had identified a deficiency in internal
controls, which was designated a "material weakness." The material weakness
indicated that there was inadequate segregation of duties within our accounting
function. We believe this resulted from continued cost cutting efforts, which
resulted in the termination of various accounting personnel during 2002 and
2003. Management believes that sufficient compensating controls have been
implemented to minimize the risks associated with this material weakness,
including additional Chief Executive Officer and Board of Directors oversight.


                                     PART II

ITEM 1.  LEGAL PROCEEDINGS

On May 1, 2003, Citibank (West), FSB, filed suit in San Diego Superior Court,
North County Division, against one of our subsidiaries, Quality Software
Associates, Inc. ("QSA"), and Mark Scovel, the individual from whom we acquired
QSA in March 2001. CitiBank seeks to recover $8,000 of credit card indebtedness
under a credit card held by QSA that was personally guaranteed by Mr. Scovel. On
June 24, 2003, Mr. Scovel filed a cross-complaint against QSA and Simtrol, Inc.
claiming that Simtrol had assumed the debt in connection with its acquisition of
QSA. Mr. Scovel's complaint also seeks declaratory relief, seeking a judgment
that QSA and Simtrol are also liable for several other QSA debts, in an
aggregate amount of less than $50,000. Mr. Scovel also seeks attorneys' fees.

We have filed a cross-complaint against Mr. Scovel seeking damages of
approximately $56,000 and alleging a breach of the representations and
warranties relating to the collectibility of certain accounts receivables
contained in the Merger Agreement under which we acquired QSA.

On April 18, 2004, QSA agreed to pay Citibank (West), FSB, $5,800 in settlement
of the debt to Citibank and to pay Mr. Scovel $40,000 in settlement of all
claims. The $5,800 and $3,000 of the settlement amount to Mr. Scovel were paid
April 30. The remaining $37,000 due Mr. Scovel is due by June 15, 2004.

ITEM 2. CHANGES IN SECURITIES AND PURCHASES OF EQUITY SECURITIES

During the quarter ended March 31, 2004, we issued 2,604 shares of our common
stock for gross proceeds of $5,000 ($1.92 per share), in a private placement to
a limited number of accredited investors, including three of our directors. The
offer and sale of the shares was exempt from the registration requirements of
the Securities Act of 1933 (the "Act") pursuant to Rule 506 and Section 4(2) of
the Act. In connection with the sales, we did not conduct any general
solicitation or advertising, and we complied with the requirements of Regulation
D relating to the restrictions on the transferability of the shares issued.

On February 4, 2004, the Company completed the sale of convertible notes with
principal balance of $575,000. In conjunction with the sale, we issued warrants
to Westminster Securities to purchase 169,000 shares of our common stock at a
purchase price of $2.00, as a placement fee. Additional information regarding
these issuances of securities is set forth in note 5 to the financial statements
included in this Report.

The offers and sales of the above-described securities were exempt from the
registration requirements of the Securities Act of 1933 (the "Act") pursuant to
Rule 506 and Section 4(2) of the Act. In connection with the offers and sales,
we did not conduct any general solicitation or advertising, and we complied with
the requirements of Regulation D relating to the restrictions on the
transferability of the shares issued.


ITEM 6.  EXHIBITS AND REPORTS ON FORM 8-K


                                       14



(a)  Exhibits. The following exhibits are filed with or incorporated by
     reference into this report.

     Exhibit No. Description

     3.1  Certificate of Incorporation, including Certificate of Stock
          Designation dated September 25, 1990, and amendments dated December
          26, 1990, August 19, 1991 and October 17, 1991 (incorporated herein by
          reference to Exhibit 3-1 of the Post-Effective Amendment No. 3 to the
          Company's Registration Statement on Form S-18 (File No. 33-27040-D))

     3.2  Amended Bylaws of the Company as presently in use (incorporated herein
          by reference to Exhibit 3.2 of the Post-Effective Amendment No. 1 to
          the Company's Registration Statement on Form S-18 (File No.
          33-27040-D))

     3.3  Certificate of Amendment to Certificate of Incorporation filed on
          February 10, 1993 (incorporated herein by reference to the Company's
          Quarterly Report on Form 10-Q for the quarter ended December 31, 1992)

     3.6  Certificate of Amendment to Certificate of Incorporation filed on
          February 13, 1995 (incorporated herein by reference to the Company's
          Annual Report on Form 10-K for the year ended December 31, 1994)

     3.7  Certificate of Amendment to Certificate of Incorporation filed on
          September 8, 1995 (incorporated herein by reference to the Company's
          Annual Report on Form 10-K for the year ended December 31, 1995)

     3.9  Certificate of Amendment of Certificate of Incorporation filed on
          January 13, 1999 (incorporated herein by reference to the Company's
          Annual Report on Form 10-K for the year ended December 31, 1998, as
          amended )

     3.10 Certificate of Amendment to Certificate of Incorporation filed on June
          28, 1999 (incorporated herein by reference to the Company's Quarterly
          Report on Form 10-Q for the quarter ended June 30, 1999)

     3.11 Certificate of Amendment to Certificate of Incorporation filed on May
          7, 2004

     31.1 Certification of the Chief Executive Officer pursuant to Exchange Act
          Rule 13a-14(a).

     31.2 Certification of the Chief Financial Officer pursuant to Exchange Act
          Rule 13a-14(a).

     32.1 Certification Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant
          to Section 906 of the Sarbanes-Oxley Act of 2002.

(b)  Reports on Form 8-K:

On January 26, 2004 we filed a Form 8-K regarding the closing of a private
placement of equity securities to a limited number of accredited investors
effective January 23, 2004. On that date, we also filed a Form 8-K indicating
the resignation of Grant Thornton LLP as our independent auditors effective
January 16, 2004. On February 9, 2004, we filed a Form 8-K reporting the hiring
of Marcum & Kliegman LLP as our independent auditors and the closing of a
Convertible Note financing with a limited number of accredited investors.

                                   SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.


                                       15



                               SIMTROL, INC.

Date:    May 17, 2004          /s/ Richard W. Egan
                               -----------------------------------------
                               Chief Executive Officer
                               (Principal executive officer)


                               /s/ Stephen N. Samp
                               -----------------------------------------
                               Chief Financial Officer
                               (Principal financial and accounting officer)


                                       16



                                  EXHIBIT INDEX
Exhibit No.       Description
-----------       -----------

3.11              Certificate of Amendment to Certificate of Incorporation
                   filed on May 7, 2004

31.1              Certification of the Chief Executive Officer pursuant to
                   Exchange Act Rule 13a-14(a).

31.2              Certification of the Chief Financial Officer pursuant to
                   Exchange Act Rule 13a-14(a).

32.1              Certification Pursuant to 18 U.S.C. Section 1350, as Adopted
                   Pursuant to Section 906 of the Sarbanes-Oxley Act of
                   2002.


                                       17